Home / BusinessBusinessBloombergBusinessBloomberg·Sep 17, 2026·1 min readNovo Nordisk (NVO) Taps Anthropic AI to Develop Next-Generation MedicinesThe Ozempic maker sees a need for speed when it comes to AIView original source — Bloomberg ↗ShareCopy linkShare on XShare on FacebookRelated storiesBusinessBloombergBusinessSep 16, 2026 · 1 minNovo Will Work With Anthropic AI to Speed Drug DevelopmentBloombergTechnologyEuronewsTechnologySep 16, 2026 · 1 minDanish pharma giant Novo to use Anthropic’s Claude to advance AI drug discoveryEuronewsBusinessBloombergBusinessSep 3, 2026 · 1 minAstraZeneca, Sanofi, Boehringer Back Owkin AI to Cut Drug BottlenecksBloombergTechnologyTechRadarTechnologySep 1, 2026 · 1 minAnthropic reveals its view of how AI agents should interact with the physical worldTechRadar
BusinessBloombergBusinessSep 16, 2026 · 1 minNovo Will Work With Anthropic AI to Speed Drug DevelopmentBloomberg
TechnologyEuronewsTechnologySep 16, 2026 · 1 minDanish pharma giant Novo to use Anthropic’s Claude to advance AI drug discoveryEuronews
BusinessBloombergBusinessSep 3, 2026 · 1 minAstraZeneca, Sanofi, Boehringer Back Owkin AI to Cut Drug BottlenecksBloomberg
TechnologyTechRadarTechnologySep 1, 2026 · 1 minAnthropic reveals its view of how AI agents should interact with the physical worldTechRadar